Here are the latest updates on the approval and upcoming sales of Presvu Eye Drops:
- Government Approval: The Drug Controller General of India (DCGI) has approved Presvu Eye Drops, developed by Entod Pharmaceuticals.
- Vision Improvement: These eye drops can improve vision within 15 minutes of application.
- Sales Launch: Presvu Eye Drops will be available for sale starting next month.
- Target Condition: The eye drops are designed to treat presbyopia, a common age-related vision problem.
- Market Impact: This approval marks a significant advancement in eye care innovation in India.
- Usage Benefits: Presvu Eye Drops aim to reduce the reliance on reading glasses for individuals with presbyopia.
- Product Availability: The eye drops will be launched in the domestic market in the first week of October.
- Global Reach: Entod Pharmaceuticals plans to expand the product to emerging markets such as Africa and Southeast Asia.
- Cost: The eye drops will be available at a cost of Rs 350 per bottle.
- Expert Opinion: Dr. Aditya Sethi highlighted that Presvu Eye Drops can significantly improve near vision, enhancing the quality of life for many.
-
Which 444-Day FD Scheme Truly Maximizes Your Gains in 2025? The Surprising Rate Differences You Don’t Know About
The surprising truth behind India’s top 444-day FDs! Which bank offers the highest returns for seniors and super
-
Indian Stock Market Trends 2025: Key Insights, Top Stocks & Sector Performance for November 10, 2025
Unlock the secret pulse of Dalal Street! Discover why India’s GDP growth, CPI inflation dips, and RBI repo
-
What If Your Next Car Insurance Premium Didn’t Follow the Old Rules?
The future of car insurance premiums in India! Discover how AI, electric vehicles, and breakthrough add-ons will reshape
-
The Big Question: Why Do “Big, World-Class Banks” Matter More Than Ever?
India’s bold 2025 bank merger plans promise to reshape your financial future—but what hidden risks and surprises could
-
Is Your Digital Gold Safe? The Shocking Truth SEBI Just Revealed
Are those shiny ‘digital gold’ ads really golden opportunities—or ticking time bombs? SEBI’s latest warning reveals a hidden





